Wall Street opens lower amid Russia probe, Fed pick
October 30, 2017
Apple touches record as brokerages bullish on iPhone X demand
October 30, 2017

Cancer-drug setback sends Merck shares down again

NEW YORK (Reuters) – A setback for Merck & Co’s key cancer drug sent the drugmaker’s stock swooning on Monday for a second straight session, putting the shares on track for their biggest two-day decline in more than eight years.

Powered by WPeMatico